Ioannis Thomas
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Polyomavirus and related diseases
- Cutaneous Melanoma Detection and Management
-
- Myasthenia Gravis and Thymoma
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 10
- Cutaneous Melanoma Detection and Management 3
- Polyomavirus and related diseases 1
- CAR-T cell therapy research 1
-
- Immunotherapy and Immune Responses 1
- Co-authors
- Teresa Amaral (5 shared papers)Claus Garbe (4 shared papers)Thomas Eigentler (4 shared papers)Ulrike Leiter (4 shared papers)Andrea Forschner (3 shared papers)Andreas Meiwes (3 shared papers)Ulrike Keim (3 shared papers)Lukas Flatz (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)European Journal of Cancer (2 papers)Cancers (2 papers)The Lancet (1 paper)Nature Medicine (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Ioannis Thomas
13 papers receiving 1.2k citations
Ioannis Thomas's Hit Papers
Peers
Comparison fields: 5 of 52
- Oncology 974
- Neurology 64
- Ophthalmology 30
- Dermatology 22
- Immunology 42
Countries citing papers authored by Ioannis Thomas
This map shows the geographic impact of Ioannis Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioannis Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioannis Thomas more than expected).
Fields of papers citing papers by Ioannis Thomas
This network shows the impact of papers produced by Ioannis Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioannis Thomas. The network helps show where Ioannis Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Ioannis Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy Hit paper breakdown → | 2016 | 555 |
| 2 | Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy Hit paper breakdown → | 2016 | 484 |
| 3 | 2023 | 52 | |
| 4 | 2020 | 28 | |
| 5 | 2021 | 20 | |
| 6 | 2025 | 19 | |
| 7 | 2020 | 13 | |
| 8 | 2023 | 12 | |
| 9 | 2019 | 7 | |
| 10 | 2025 | 6 | |
| 11 | 2025 | 4 | |
| 12 | 2025 | 3 | |
| 13 | 2023 | 2 |
About Ioannis Thomas
Ioannis Thomas is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Cutaneous Melanoma Detection and Management (3 papers), Immunotherapy and Immune Responses (1 paper), Polyomavirus and related diseases (1 paper), CAR-T cell therapy research (1 paper) and Brain Metastases and Treatment (1 paper). The work is most often cited by research in Oncology (974 citations), Neurology (64 citations), Ophthalmology (30 citations), Dermatology (22 citations) and Immunology (42 citations). Ioannis Thomas has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Teresa Amaral, Claus Garbe, Thomas Eigentler, Ulrike Leiter, Andrea Forschner, Andreas Meiwes, Ulrike Keim, Lukas Flatz, Heike Niessner and Peter Martus. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Cancers, The Lancet and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.